Neurological Surgery 脳神経外科51巻4号

2023年07月発行

特集 下垂体腫瘍診療の新フェーズ—変革期の疫学・診断・治療における必須知識 Ⅲ 下垂体腫瘍の診断

下垂体腫瘍のWHO組織分類

著者： 西岡宏¹

所属機関： ¹虎の門病院間脳下垂体外科

ページ範囲：P.642 - P.653

Point
・WHO 2022では，下垂体腺腫から下垂体神経内分泌腫瘍（PitNET）へ名称が変更された．
・前回の分類から下垂体転写因子の免疫組織化学が組織診断に導入されたが，WHO 2022では転写因子（PIT1, TPIT, SF1）を基本とした分類になった．
・下垂体細胞腫など後葉腫瘍の4組織型は，下垂体細胞（pituicyte）由来の腫瘍として統一された．

参考文献

1）西岡　宏，井下尚子：下垂体腫瘍の2017年WHO組織分類．No Shinkei Geka 47：597-606, 2019

2）Nishioka H, Inoshita N：New WHO classification of pituitary adenomas（4th edition）：assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol 35：57-61, 2018

3）Rindi G, Inzani F：Neuroendocrine neoplasm update：toward universal nomenclature. Endocr Relat Cancer 27：R211-R218, 2020　doi：10.1530/ERC-20-0036

4）Asa SL, et al：Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33：6-26, 2022

5）Lopes MBS, et al：Pituitary adenoma/pituitary neuroendocrine tumour. WHO Classification of Tumours, 5th edition. Central Nervous System tumours. IARC, Lyon, 2021

6）Asa SL, et al；attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016：From pituitary adenoma to pituitary neuroendocrine tumor（PitNET）：an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24：C5-C8, 2017　doi：10.1530/ERC-17-0004

7）Asa SL, et al：Pituitary neuroendocrine tumors（PitNETs）：nomenclature evolution, not clinical revolution. Pituitary 23：322-325, 2020

8）Ho K, et al：Pituitary neoplasm nomenclature workshop：does adenoma stand the test of time? J Endocr Soc 5：bvaa205, 2021　doi：10.1210/jendso/bvaa205

9）Nishioka H, et al：The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26：349-355, 2015

10）Mete O, Asa SL：Structure, function, and morphology in the classification of pituitary neuroendocrine tumors：the importance of routine analysis of pituitary transcription factors. Endocr Pathol 31：330-336, 2020

11）Raverot G, et al：Aggressive pituitary tumours and pituitary carcinomas. Nat Rev Endocrinol 17：671-684, 2021

12）Dai C, et al：Refractory pituitary adenoma：a novel classification for pituitary tumors. Oncotarget 7：83657-83668, 2016

13）Nishioka H：Aggressive pituitary tumors（PitNETs）. Endocr J 70：241-248, 2023

14）Trouillas J, et al：Aggressive pituitary tumours and carcinomas：two sides of the same coin? Eur J Endocrinol 178：C7-C9, 2018　doi：10.1530/EJE-18-0250

15）Trouillas J, et al：A new prognostic clinicopathological classification of pituitary adenomas：a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126：123-135, 2013

16）Mete O, et al：Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 37：1694-1699, 2013

17）Goschzik T, et al：Genomic alterations of adamantinomatous and papillary craniopharyngioma. J Neuropathol Exp Neurol 76：126-134, 2017

18）Fukuhara N, et al：Immunohistochemistry or molecular analysis：which method is better for subtyping craniopharyngioma? Endocr Pathol 32：262-268, 2021